Clinical Trial Update: A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline [Phase 2]

View source ↗

Summary

A Phase 2 rollover study evaluating ixabepilone in metastatic breast cancer patients previously treated with an anthracycline; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: R-Pharm | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED